Answers are grounded in this paper and cite their sources.
To compare the effect of ritonavir on plasma amprenavir pharmacokinetics, healthy adults received either fosamprenavir (700 mg twice a day [BID]) or amprenavir (600 mg BID) alone and in combination with ritonavir (100 mg BID). Ritonavir increased plasma amprenavir pharmacokinetic parameters to a similar extent when coadministered with either fosamprenavir or amprenavir.
No takes yet. Share an insight, caveat, or question.
Wire et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: